Rocket Pharmaceuticals (RCKT) Insider Trading & Ownership → The system that called 2023’s top 7 stocks is at it again… (From WealthPress) (Ad) Free RCKT Stock Alerts $23.63 -0.04 (-0.17%) (As of 04/24/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Rocket Pharmaceuticals (NASDAQ:RCKT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage31.10%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$12.28 M Get RCKT Insider Trade Alerts Want to know when executives and insiders are buying or selling Rocket Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address RCKT Insider Buying and Selling by Quarter Ad Wealthpin ProOne trade. One ticker. One week. Do you want to target weekly income of up to $2k or more… Starting with just $500... With just one trade per week? Well, then you should click here to see this free training. Rocket Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/22/2024John MilitelloInsiderSell833$22.87$19,050.71 4/15/2024David P SouthwellDirectorSell10,000$24.05$240,500.00 4/12/2024David P SouthwellDirectorSell70,000$24.36$1,705,200.00 4/8/2024Mark Andrew WhiteInsiderSell12,532$24.64$308,788.48 3/21/2024Gotham MakkerDirectorSell274,000$28.43$7,789,820.00 3/21/2024John MilitelloInsiderSell2,490$28.10$69,969.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 2/29/2024John MilitelloInsiderSell10,000$29.84$298,400.00 2/29/2024Martin WilsonGeneral CounselSell4,100$29.33$120,253.00 2/16/2024Gaurav ShahCEOSell20,272$29.84$604,916.48 2/16/2024Kinnari PatelInsiderSell7,132$29.84$212,818.88 2/16/2024Martin WilsonGeneral CounselSell3,576$29.84$106,707.84 1/22/2024John MilitelloInsiderSell638$27.20$17,353.60 11/15/2023Gotham MakkerDirectorSell20,000$22.53$450,600.00 10/20/2023John MilitelloInsiderSell564$17.06$9,621.84 9/28/2023Gotham MakkerDirectorSell10,312$21.03$216,861.36 8/17/2023Gaurav ShahCEOSell4,767$15.47$73,745.49 8/17/2023Kinnari PatelInsiderSell1,534$15.47$23,730.98 7/20/2023John MilitelloInsiderSell573$19.03$10,904.19 (Data available from 1/1/2013 forward) RCKT Insider Trading Activity - Frequently Asked Questions Who is on Rocket Pharmaceuticals's Insider Roster? The list of insiders at Rocket Pharmaceuticals includes David P Southwell, Gaurav Shah, Gotham Makker, John Militello, Jonathan David Schwartz, Kinnari Patel, Mark Andrew White, Martin Wilson, and Rtw Investments, Lp. Learn more on insiders at RCKT. What percentage of Rocket Pharmaceuticals stock is owned by insiders? 31.10% of Rocket Pharmaceuticals stock is owned by insiders. Learn more on RCKT's insider holdings. Which Rocket Pharmaceuticals insiders have been buying company stock? The following insider purchased RCKT shares in the last 24 months: Rtw Investments, Lp ($19,999,997.00). How much insider buying is happening at Rocket Pharmaceuticals? Insiders have purchased a total of 1,355,932 RCKT shares in the last 24 months for a total of $19,999,997.00 bought. Which Rocket Pharmaceuticals insiders have been selling company stock? The following insiders have sold RCKT shares in the last 24 months: David P Southwell ($1,945,700.00), Gaurav Shah ($911,079.61), Gotham Makker ($8,457,281.36), John Militello ($468,977.64), Jonathan David Schwartz ($67,796.42), Kinnari Patel ($236,549.86), Mark Andrew White ($308,788.48), and Martin Wilson ($226,960.84). How much insider selling is happening at Rocket Pharmaceuticals? Insiders have sold a total of 471,416 Rocket Pharmaceuticals shares in the last 24 months for a total of $12,623,134.21 sold. More Insider Trading Tools from MarketBeat Related Companies: TG Therapeutics Insider Ownership Dyne Therapeutics Insider Ownership Arvinas Insider Ownership Keros Therapeutics Insider Ownership Rhythm Pharmaceuticals Insider Ownership Vera Therapeutics Insider Ownership Maravai LifeSciences Insider Ownership Merus Insider Ownership Corcept Therapeutics Insider Ownership Amphastar Pharmaceuticals Insider Ownership Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Pagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1 This page (NASDAQ:RCKT) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe #1 Crypto for 2024InvestorPlaceEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American Alternative1970’s computer coder issues shocking A.I. warningTradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rocket Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
